Authors have studied the antitumor efficacy of contact radiation therapy (CRT) in combination with a chlorin-based photosensitizer (PS) in an experiment on laboratory animals with transplanted tumors. The experimental study was performed in 50 white outbred rats weighing 250±50 g. Subcutaneously transplanted Pliss lymphosarcoma (PLS) and alveolar liver cancer RS1 (RS1) were used as tumor models. Chlorinbased PS photolon (RUE «Belmedpreparaty», Republic Belarus) was injected intravenously at a dose of 2.5 mg/kg. The radiation sessions were carried out 2.5–4 hours (depending on the tumor model) after the administration of the PS using the device «microSelectron HDR V3 Digital» («Nucletron», Netherlands) with a 192-Ir radiation source in single focal doses 5 and 10 Gy. All laboratory animals (for PLS and RS1) were subdivided into 5 groups of 5 animals each: intact control, CRT 5 Gy, CRT 10 Gy, PS + CRT 5 Gy, PS + CRT 10 Gy. For the PLS tumor model – on the 14th day from the beginning of the experiment Vav. in groups were 26.31±5.81; 22.45±6.97; 18.99±4.86; 10.75±5.18 and 28.06±2.85 cm3, respectively (p˂0.05). The coefficients of tumor growth inhibition in the experimental groups were 14.67%, 27.82%, 59.14% and 6.65%, respectively. The frequency of complete tumor regressions 60 days after the start of the experiment was 0%, 20%, 20%, 60%, and 20%, respectively. On RS1 tumor model – on the 14th day from the beginning of the experiment Vav. in groups were 4.48±1.03; 0.80±0.21; 0.29±0.09; 0.19±0.07 and 0.32±0.08 cm3, respectively (p=0.009). The coefficients of tumor growth inhibition in the experimental groups were 82.14%, 93.53%, 95.76% and 92.86%, respectively. The frequency of complete tumor regressions 60 days after the start of the experiment was 0%, 0%, 20%, 0%, and 0%, respectively. Systemic administration of chlorin-based PS before the CRT session increases the antitumor efficacy of radiation therapy in animals with transplantable tumors of different histological structure and growth patterns. The data obtained indicate that further studies of the radiosensitizing properties of PS are promising.

A study of the technical and dosimetry characteristics of brachytherapy afterloaders and applicators was carried out. Ring applicator has been taken as an example, the correctness of positioning of a radiation source (RS) inside the applicators was tested as part of the comissioning and quality control procedure of the brachytherapy applicators. The magnitudes of inconsistencies in the position of RS were established when planning and implementing treatment plans for radiation therapy. The identification of the values of the discrepancy was carried out using the obtained X-ray images of the applicator at the time of the implementation of the irradiation plans. The treatment plan was a sequential positioning of RS in the body of the applicator in each active position with a minimum step from the tip to the vaginal part of the applicator. The X-ray image was obtained by locating the source sequentially at each active position of the applicator. When carrying out dosimetric planning, 3 methods of applicator reconstruction were used. The analysis revealed that the applicator reconstruction method affects the magnitude of the discrepancy in determining the position of the source in the lumen of the applicator ring. Using the methods of statistical analysis, the mean, median, maximum and minimum values of the detected deviations were calculated. The results are presented in the form of tables and graphs for all investigated stop positions of IRS. Based on the results of the study, we consider it expedient to carry out quality control procedures when putting applicators into clinical operation. Based on the results obtained, we consider it acceptable to conduct a quality control procedure for the positioning accuracy of radiation sources in the applicators at least 1 time per month. Taking into account the results of the study when carrying out dosimetric planning will improve the quality of the irradiation sessions using the brachytherapy method, thereby improving the quality of oncological care for the population.